I consider Dale's entities to, at least in part, be our financing arm. The share structure was outlined in a filing some years ago, which detailed how corporate insiders would be designated as the nominee owners of Cede shares placed in the accounts, with shares issued to and from the company-controlled beneficial ownership account.
We saw Baudax tried to mask their activity by using merger subs. SpongeTech used certificated shares, originally issued to nominee account holders, who would convert the shares into Cede (digital) form. I was able to identify two such accounts and knew, when the Cede shares in those accounts were converted back into certificate form, that those shares would then be retired. So a company with 2 billion authorized and issued shares, proved that there were a billion shares that could not be certificated, because brokerages could not verify the authenticity of the shares. The corrupt SEC just forced a new Transfer Agent to issue an additional 1 billion shares, and the bankruptcy judge failed to order a list of shareholders, even though that was required in a bankruptcy filing. We got the list, anyway, and the Electronic Blue Sheet trading records, through subpoena power granted to us by the bankruptcy judge.
In all cases above, as the shares were transferred from the companies to the nominees, the transactions would show as buys and sells, when they were actually only transfers of shares between the company-controlled accounts.
That's why in one of my posts, I say, "As our latest Form 4 continues to disappear and reappear, even this morning, we may need to consider who the beneficiary of these shares may be. Baudax is still a contender. But another possibility may be that Novavax will receive these shares in a stock-for-stock merger agreement." I do not accept that our latest Form 4 reflects true sells by Dale's entities. I think those transactions only reflect the accumulation of shares to be transferred in a stock-for-stock merger agreement.
And I discussed our previous recall of loaned shares, and very eagerly anticipate the next recall of our loaned shares. How would that help us, at all, if the company doesn't own the loaned shares?
I have been saying for years that the Form 4's may not be reflecting actual buys and sells.
In fairness, without having access to the Transfer Journal, I can't prove that these shares are just being transferred between company-controlled accounts. But we'll see soon enough, especially if the company recalls their loaned shares, and completes a stock-for-stock merger agreement without issuing new shares.
